Details
- Date: Wednesday, November 12, 2025
- In-Person Time: 12:00 p.m. – 5:00 p.m. *Time is subject to change
- Virtual Time: 1:15 p.m. – 5:00 p.m.
- Delivery: Hybrid *A virtual option is available
- Location: Liuna Station, 360 James Street North, Hamilton, ON
Target Audience
Family Physicians, Specialists, Physician Assistants, Optometrists, Pharmacists, International Medical Graduates (IMGs), Nurse Educators/Practitioners, Dietitians, and Residents.
Overall Learning Objectives
At the end of this activity, the learners will be able to:
- Analyze current evidence supporting strategies for the prevention and delay of type 1 diabetes.
- Recognize clinical presentations and diagnostic criteria of diabetes-related gastrointestinal complications.
- Evaluate therapeutic approaches to preventing and managing kidney disease in individuals with diabetes.
- Apply evidence supporting the combined use of SGLT2 inhibitors and GLP-1 receptor agonists for cardiovascular and renal protection in diabetes care.
- Discuss complex case examples to integrate pathophysiology, diagnosis, and management strategies in diabetes care.
Registration Information
Please note that changes to your attendance format (switching between in-person and virtual participation) will no longer be permitted after 11:59 PM on November 8, which is three days prior to the start of the program.
Any requests to change your participation format after this deadline will not be accommodated. Additionally, fee adjustments may apply for format changes made before the deadline, and full payment must be received before virtual access credentials can be issued.